03:56 AM EDT, 06/09/2026 (MT Newswires) -- Zai Lab ( ZLAB ) received approval from China's National Medical Products Administration for Tivdak to treat adults with recurrent or metastatic cervical cancer whose disease progressed on or after chemotherapy, the company said Monday. The approval was supported by results from a phase 3 trial in which Tivdak showed a 45% reduction...

LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Computershare Trustees (Jersey) Limited as trustee of the Schroders Employee Benefit Trust (b) Owner or controller of interests and short positions disclosed,...

03:58 AM EDT, 06/09/2026 (MT Newswires) -- Moderna ( MRNA ) and the University of Oxford have received authorization from the UK Medicines and Healthcare products Regulatory Agency to begin a phase 1/2 study of mRNA-4194, an investigational cancer vaccine for people with lynch syndrome, according to a Monday statement. Lynch syndrome is an inherited condition that results in high...

SYDNEY and MUNICH, June 9, 2026 /PRNewswire/ -- Infomedia, a global leader in automotive aftersales technology, has completed the acquisition of Veact GmbH, a leading European provider of data activation, predictive service marketing, and aftersales customer management solutions in the automotive industry. Financial terms of the transaction were not disclosed. This acquisition underscores Infomedia's strategy to broaden its global footprint...